We are live on ! Find out more
Mitsubishi UFJ Asset Management

Mitsubishi UFJ Asset Management Portfolio holdings

AUM $180B
1-Year Est. Return 37.51%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$12.9B
AUM Growth
+$2.06B
Cap. Flow
+$696M
Cap. Flow %
5.38%
Top 10 Hldgs %
21.98%
Holding
1,047
New
43
Increased
776
Reduced
154
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Consumer Discretionary 12.53%
3 Healthcare 12.45%
4 Financials 11.19%
5 Communication Services 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRG icon
851
Kite Realty
KRG
$5.24B
$435K ﹤0.01%
29,090
+3,707
+15% +$49.2K
NVEC icon
852
NVE Corp
NVEC
$565M
$431K ﹤0.01%
7,664
+5,695
+289% +$293K
ESRT icon
853
Empire State Realty Trust
ESRT
$802M
$425K ﹤0.01%
45,564
+536
+1% +$4.23K
GAP
854
The Gap Inc
GAP
$7.55B
$408K ﹤0.01%
20,189
+3,202
+19% +$67.2K
ALEX
855
DELISTED
Alexander & Baldwin
ALEX
$407K ﹤0.01%
+23,692
New +$346K
PGEN icon
856
Precigen
PGEN
$2.46B
$407K ﹤0.01%
+39,915
New +$259K
DINO icon
857
HF Sinclair
DINO
$15.2B
$400K ﹤0.01%
15,475
+2,435
+19% +$55.2K
IRT icon
858
Independence Realty Trust
IRT
$3.93B
$399K ﹤0.01%
29,729
AKR icon
859
Acadia Realty Trust
AKR
$2.83B
$396K ﹤0.01%
27,938
+332
+1% +$4.17K
RCKT icon
860
Rocket Pharmaceuticals
RCKT
$382M
$391K ﹤0.01%
7,137
-2,998
-30% -$109K
IBRX icon
861
ImmunityBio
IBRX
$8.05B
$388K ﹤0.01%
+29,101
New +$280K
NTLA icon
862
Intellia Therapeutics
NTLA
$1.68B
$382K ﹤0.01%
7,026
-2,912
-29% -$106K
MAC icon
863
Macerich
MAC
$6.96B
$378K ﹤0.01%
35,408
+562
+2% +$5.11K
CRL icon
864
Charles River Laboratories
CRL
$13.5B
$375K ﹤0.01%
1,500
-137
-8% -$32.6K
PAGS icon
865
PagSeguro Digital
PAGS
$2.48B
$368K ﹤0.01%
6,477
+730
+13% +$32.8K
VRE
866
DELISTED
Veris Residential
VRE
$368K ﹤0.01%
29,515
+3,501
+13% +$44.6K
DCO icon
867
Ducommun
DCO
$2.98B
$366K ﹤0.01%
6,810
-7,254
-52% -$313K
OPI
868
DELISTED
Office Properties Income Trust
OPI
$366K ﹤0.01%
16,104
+209
+1% +$4.57K
SGMO
869
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$358K ﹤0.01%
22,962
+6,099
+36% +$71.4K
LPRO
870
DELISTED
Open Lending Corp
LPRO
$354K ﹤0.01%
+10,134
New +$295K
OMCL icon
871
Omnicell
OMCL
$1.68B
$351K ﹤0.01%
2,921
-634
-18% -$62.2K
KRYS icon
872
Krystal Biotech
KRYS
$9.68B
$348K ﹤0.01%
5,808
+2,222
+62% +$111K
PSN icon
873
Parsons
PSN
$5.15B
$348K ﹤0.01%
9,567
+2,747
+40% +$92.3K
CRSP icon
874
CRISPR Therapeutics
CRSP
$5.23B
$345K ﹤0.01%
2,256
-729
-24% -$86.2K
ESE icon
875
ESCO Technologies
ESE
$7.65B
$344K ﹤0.01%
3,329
+25
+0.8% +$2.35K

Similar funds

Mitsubishi UFJ Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Mitsubishi UFJ Asset Management held 1,047 positions worth $12.9B, up 19% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mitsubishi UFJ Asset Management deployed $696M of net new capital in Q4 2020, opening 43 new positions and adding to 776 existing holdings. Its largest new stake was Goosehead Insurance: 40,600 shares worth $5.07M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $20.2M trimmed.

  • Mitsubishi UFJ Asset Management's largest Q4 2020 buy was Goosehead Insurance: 40,600 shares worth $5.07M.
  • Mitsubishi UFJ Asset Management added most to Tesla in Q4 2020, an estimated $42.1M increase.
  • Mitsubishi UFJ Asset Management's biggest Q4 2020 reduction was Amgen, cutting an estimated $20.2M.
  • Mitsubishi UFJ Asset Management fully exited E*Trade Financial Corporation in Q4 2020, selling an estimated $2.31M.
  • Mitsubishi UFJ Asset Management's ten largest holdings make up 22% of its $12.9B portfolio in Q4 2020.
  • Mitsubishi UFJ Asset Management opened 43 new positions and closed 22 in Q4 2020.
  • Mitsubishi UFJ Asset Management's portfolio value rose 19% quarter-over-quarter to $12.9B.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.